T Shaw
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Chronic Lymphocytic Leukemia Research, T-cell and B-cell Immunology
Most-Cited Works
- → Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks(2006)1,631 cited
- → The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial(2006)1,050 cited
- → Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies(2008)240 cited
- → B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience(2003)130 cited